Search results
PTC Therapeutics (NASDAQ:PTCT) Upgraded at Raymond James
ETF DAILY NEWS· 19 hours agoPTC Therapeutics (NASDAQ:PTCT – Get Free Report) was upgraded by Raymond James from an “underperform” rating to a “market perform” rating in a research ...
PTC Therapeutics stock target raised on re-evaluation of Translarna By Investing.com
Investing.com· 12 hours agoOn Monday, Jefferies maintained a Buy rating on PTC Therapeutics (NASDAQ:PTCT) and increased the...
PTC Therapeutics Stock Soars As Its Biggest Drug 'Lives To Fight Another Day'
Investor's Business Daily· 9 hours agoTwice — in September and January — the Committee for Medicinal Products for Human Use issued a...
PTCT stock target raised, maintains sell rating on favorable regulatory development By Investing.com
Investing.com· 10 hours agoOn Monday, Goldman Sachs updated its view on PTC Therapeutics shares (NASDAQ:PTCT), raising the...
EC withholds negative stance on Translarna in Europe By Investing.com
Investing.com· 14 hours agoPTC Therapeutics, Inc. (NASDAQ: NASDAQ:PTCT) disclosed on Monday that the European Commission (EC)...
PTC Therapeutics Pauses 2024 Revenue Guidance After European Commission Requests Reevaluation of...
Market Watch· 17 hours agoPTC Therapeutics has paused its 2024 revenue guidance after the European Commission decided against adopting a committee's negative opinion on the annual ...
PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™
FOX 23 News Albany· 7 days agoPTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the FDA has accepted for filing the...
European Commission, in ‘unprecedented’ move, declines to revoke approval of PTC Duchenne drug
BioPharma Dive via Yahoo Finance· 17 hours agoRather than endorse the recommendation of the EMA, the commission called for a new review for...
EVP & CHIEF MEDICAL OFFICER Golden Lee Scott sold 175 shares of PTC Therapeutics Inc [PTCT] – Knox...
Knox Daily· 5 days agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. PTC Therapeutics Inc shares valued at $5,744 ...
Cencora Data Breach Results in Leak of Confidential Information Provided to PTC Therapeutics, Inc. |...
JD Supra· 4 days agoMay 15, 2024, Cencora, Inc. filed a notice of data breach with the Attorney General of California after discovering that a cyberattack compromised information provided to Cencora by